Trubridge, Inc. (TBRG) — SEC Filings
Trubridge, Inc. (TBRG) — 50 SEC filings. Latest: 8-K (Dec 1, 2025). Includes 22 8-K, 8 SC 13G/A, 5 10-Q.
View Trubridge, Inc. on SEC EDGAR
Overview
Trubridge, Inc. (TBRG) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 1, 2025: On November 25, 2025, TruBridge, Inc. entered into a material definitive agreement. This agreement also created a direct financial obligation for the registrant. The filing includes financial statements and exhibits related to this event.
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 2 bullish, 48 neutral. The dominant filing sentiment for Trubridge, Inc. is neutral.
Filing Type Overview
Trubridge, Inc. (TBRG) has filed 22 8-K, 5 10-Q, 2 DEF 14A, 1 8-K/A, 2 10-K, 8 SC 13G/A, 5 SC 13D/A, 2 10-K/A, 2 SC 13D, 1 SC 13G with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of TBRG's 38 recent filings, 0 were flagged as high-risk, 24 as medium-risk, and 14 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $86.106M |
| Net Income | $5.602M |
| EPS | $0.37 |
| Debt-to-Equity | 1.21 |
| Cash Position | $19.920M |
| Operating Margin | 49.17% |
| Total Assets | $399.412M |
| Total Debt | $164.343M |
Key Executives
- John E. Smith
- Sarah Lee
- Christopher L. Fowler
- J. Boyd Douglas
- Damien Leonard
- Andrew Freedman, Esq.
- James R. K. Porter
- David M. Smith
- Robert E. Watson, Jr.
- William D. Denson
- Andris Upitis
- Kevin C. Timken
- David A. Curtiss
- Ruben Visser
- Ethan Johnson
Industry Context
TruBridge operates within the healthcare technology and services sector, providing solutions that aim to improve financial health and patient care for healthcare providers. This industry is characterized by increasing regulatory scrutiny, a growing demand for efficiency and cost-containment, and continuous technological innovation. Companies in this space often face pressure to demonstrate clear ROI and compliance with healthcare-specific data privacy and security standards.
Top Tags
financial-reporting (9) · corporate-governance (7) · ownership-change (6) · sec-filing (5) · 8-K (4) · amendment (4) · material-agreement (4) · schedule-13d (4) · TruBridge (4) · Healthcare IT (3)
Executive Compensation
From the most recent DEF 14A filing (Mar 27, 2024):
- Christopher L. Flower — Member
- J. Boyd Douglas — Member
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Total Revenues (Q3 2025) | $86.106M | Increased from $84.700M in Q3 2024, a 1.66% rise. |
| Net Income (Q3 2025) | $5.602M | Swing from a net loss of $9.148M in Q3 2024. |
| Diluted EPS (Q3 2025) | $0.37 | Improved from $(0.61) in Q3 2024. |
| Total Revenues (YTD Q3 2025) | $259.043M | Increased from $254.416M in YTD Q3 2024, a 1.82% rise. |
| Net Income (YTD Q3 2025) | $8.641M | Swing from a net loss of $15.390M in YTD Q3 2024. |
| Diluted EPS (YTD Q3 2025) | $0.58 | Improved from $(1.04) in YTD Q3 2024. |
| Cash and Cash Equivalents | $19.920M | Increased from $12.324M at December 31, 2024. |
| Net Cash from Operating Activities (YTD Q3 2025) | $28.107M | Increased from $21.839M in YTD Q3 2024. |
| Income Tax Benefit (Q3 2025) | $4.250M | Contrasts with a $7.553M provision in Q3 2024, significantly impacting net income. |
| Interest Expense Reduction (Q3 2025) | $1.030M | Reduced from $4.033M in Q3 2024 to $3.003M in Q3 2025. |
| Q2 2025 Revenue | $65.2M | Increased 12.2% from $58.1M in Q2 2024 |
| Q2 2025 Net Income | $10.5M | Increased 28.0% from $8.2M in Q2 2024 |
| Revenue Growth | 12.2% | Year-over-year increase for Q2 2025 |
| Net Income Growth | 28.0% | Year-over-year increase for Q2 2025 |
| Financial Health Segment Revenue Q2 2025 | $35.8M | Increased 13.7% from Q2 2024 |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Trubridge, Inc. (TBRG)?
Trubridge, Inc. has 50 recent SEC filings from Jan 2024 to Dec 2025, including 22 8-K, 8 SC 13G/A, 5 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of TBRG filings?
Across 50 filings, the sentiment breakdown is: 2 bullish, 48 neutral. The dominant sentiment is neutral.
Where can I find Trubridge, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Trubridge, Inc. (TBRG) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Trubridge, Inc.?
Key financial highlights from Trubridge, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for TBRG?
The investment thesis for TBRG includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Trubridge, Inc.?
Key executives identified across Trubridge, Inc.'s filings include John E. Smith, Sarah Lee, Christopher L. Fowler, J. Boyd Douglas, Damien Leonard and 13 others.
What are the main risk factors for Trubridge, Inc. stock?
Of TBRG's 38 assessed filings, 0 were flagged high-risk, 24 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from Trubridge, Inc.?
Forward guidance and predictions for Trubridge, Inc. are extracted from SEC filings as they are enriched.